The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HDAC I/IIb selective inhibitor purinostat mesylate in relapsed and refractory diffuse large B-cell lymphoma: A single agent phase IIa trial.
 
Lijuan Chen
Employment - Zenitar
Leadership - Zenitar
Stock and Other Ownership Interests - Zenitar
Honoraria - Zenitar
Consulting or Advisory Role - Zenitar
Patents, Royalties, Other Intellectual Property - Zenitar
 
Linyu Yang
No Relationships to Disclose
 
Jie Wang
No Relationships to Disclose
 
Rui Liang
Employment - Zenitar
Leadership - Zenitar
 
He Li
No Relationships to Disclose
 
Mengke Liu
No Relationships to Disclose
 
Yi Wen
No Relationships to Disclose
 
Lin Liu
No Relationships to Disclose
 
Xiaoqiong Tang
No Relationships to Disclose
 
Jieping Li
No Relationships to Disclose
 
Xun Lai
No Relationships to Disclose
 
Huijing Wu
No Relationships to Disclose
 
Yajun Li
No Relationships to Disclose
 
Shihua Huang
No Relationships to Disclose
 
Lihua Yang
No Relationships to Disclose
 
Ke Tan
Employment - Zenitar
Leadership - Zenitar
 
Li Wang
No Relationships to Disclose
 
Ting Niu
No Relationships to Disclose
 
Weili Zhao
No Relationships to Disclose